Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 151
Filter
1.
J Transl Med ; 21(1): 399, 2023 06 19.
Article in English | MEDLINE | ID: mdl-37337244

ABSTRACT

BACKGROUND: Bone marrow metastasis (BMM) is underestimated in gastric cancer (GC). GC with BMM frequently complicate critical hematological abnormalities like diffused intravascular coagulation and microangiopathic hemolytic anemia, which constitute a highly aggressive GC (HAGC) subtype. HAGC present a very poor prognosis with peculiar clinical and pathological features when compared with not otherwise specified advanced GC (NAGC). But the molecular mechanisms underlying BMM from GC remain rudimentary. METHODS: The transcriptomic difference between HAGC and NAGC were analyzed. Genes that were specifically upregulated in HAGC were identified, and their effect on cell migration and invasion was studied. The function of ACTN2 gene were confirmed by GC cell lines, bone-metastatic animal model and patients' tissues. Furthermore, the molecular mechanism of ACTN2 derived-BMM was explored by multiple immunofluorescence staining, western blot, chromatin immunoprecipitation, and luciferase reporter assays. RESULTS: We elucidated the key mechanisms of BMM depending on the transcriptomic difference between HAGC and NAGC. Five genes specifically upregulated in HAGC were assessed their effect on cell migration and invasion. The ACTN2 gene encoding protein α-Actinin-2 was detected enhanced the metastatic capability and induced BMM of GC cells in mouse models. Mechanically, α-Actinin-2 was involved in filopodia formation where it promoted the Actin filament cross-linking by replacing α-Actinin-1 to form α-Actinin-2:α-Actinin-4 complexes in GC cells. Moreover, NF-κB subunit RelA and α-Actinin-2 formed heterotrimers in the nuclei of GC cells. As a direct target of RelA:α-Actinin-2 heterotrimers, the ACTN2 gene was a positive auto-regulatory loop for α-Actinin-2 expression. CONCLUSIONS: We demonstrated a link between filopodia, BMM and ACTN2 activation, where a feedforward activation loop between ACTN2 and RelA is established via actin in response to distant metastasis. Given the novel filopodia formation function and the new mechanism of BMM in GC, we propose ACTN2 as a druggable molecular vulnerability that may provide potential therapeutic benefit against BMM of GC.


Subject(s)
Actinin , Bone Marrow Neoplasms , Stomach Neoplasms , Animals , Mice , Actinin/genetics , Actinin/metabolism , Cell Line, Tumor , NF-kappa B/metabolism , Pseudopodia/metabolism , Pseudopodia/pathology , Stomach Neoplasms/pathology
2.
J Pathol ; 258(1): 26-37, 2022 09.
Article in English | MEDLINE | ID: mdl-35607980

ABSTRACT

In Alport mice, activation of the endothelin A receptor (ETA R) in mesangial cells results in sub-endothelial invasion of glomerular capillaries by mesangial filopodia. Filopodia deposit mesangial matrix in the glomerular basement membrane (GBM), including laminin 211 which activates NF-κB, resulting in induction of inflammatory cytokines. Herein we show that collagen α1(III) is also deposited in the GBM. Collagen α1(III) localized to the mesangium in wild-type mice and was found in both the mesangium and the GBM in Alport mice. We show that collagen α1(III) activates discoidin domain receptor family, member 1 (DDR1) receptors both in vitro and in vivo. To elucidate whether collagen α1(III) might cause podocyte injury, cultured murine Alport podocytes were overlaid with recombinant collagen α1(III), or not, for 24 h and RNA was analyzed by RNA sequencing (RNA-seq). These same cells were subjected to siRNA knockdown for integrin α2 or DDR1 and the RNA was analyzed by RNA-seq. Results were validated in vivo using RNA-seq from RNA isolated from wild-type and Alport mouse glomeruli. Numerous genes associated with podocyte injury were up- or down-regulated in both Alport glomeruli and cultured podocytes treated with collagen α1(III), 18 of which have been associated previously with podocyte injury or glomerulonephritis. The data indicate α2ß1 integrin/DDR1 co-receptor signaling as the dominant regulatory mechanism. This may explain earlier studies where deletion of either DDR1 or α2ß1 integrin in Alport mice ameliorates renal pathology. © 2022 Boys Town National Research Hospital. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.


Subject(s)
Nephritis, Hereditary , Podocytes , Animals , Basement Membrane/pathology , Collagen Type III , Collagen Type IV/genetics , Discoidin Domain Receptor 1/genetics , Glomerular Basement Membrane/pathology , Humans , Integrin alpha2beta1 , Mice , Mice, Knockout , Nephritis, Hereditary/genetics , Nephritis, Hereditary/pathology , Podocytes/pathology , Pseudopodia/pathology , RNA
3.
PLoS One ; 16(5): e0252428, 2021.
Article in English | MEDLINE | ID: mdl-34043722

ABSTRACT

Diaphanous related formins are highly conserved proteins regulated by Rho-GTPases that act as actin nucleation and assembly factors. Here we report the functional characterization of a non-inherited heterozygous FMNL2 p.L136P mutation carried by a patient who presented with severe very early onset inflammatory bowel disease (IBD). We found that the FMNL2 L136P protein displayed subcellular mislocalization and deregulated protein autoinhibition indicating gain-of-function mechanism. Expression of FMNL2 L136P impaired cell spreading as well as filopodia formation. THP-1 macrophages expressing FMNL2 L136P revealed dysregulated podosome formation and a defect in matrix degradation. Our data indicate that the L136P mutation affects cellular actin dynamics in fibroblasts and immune cells such as macrophages.


Subject(s)
Formins/genetics , Inflammatory Bowel Diseases/genetics , Cell Differentiation , Cell Line , Chronic Disease , Formins/chemistry , Formins/metabolism , Humans , Inflammatory Bowel Diseases/pathology , Macrophages/cytology , Macrophages/metabolism , Podosomes/metabolism , Polymorphism, Single Nucleotide , Pseudopodia/metabolism , Pseudopodia/pathology
4.
Int J Biol Sci ; 17(7): 1716-1730, 2021.
Article in English | MEDLINE | ID: mdl-33994856

ABSTRACT

N-myc downstream regulated gene-1 (NDRG1) has been identified as a putative metastasis suppressor gene and proved to be a key player in cancer spreading and proliferation in our previous work. However, the effects of NDRG1 on tumor invasion and the mechanisms behind it are rarely understood. Here we provided in silico evidence that NDRG1 plays a crucial role in actin reorganization in colorectal cancer (CRC). Through in vitro experiments, we next observed filopodia formation was altered in NDRG1-modified cell lines, while cell division cycle-42 (CDC42) displayed excessive activation in NDRG1-silenced cells. Mechanistically, NDRG1 loss disrupts the binding between RhoGDIα and CDC42 and triggers the activation of CDC42 and the downstream cascades PAK1/Cofilin, thereby promotes the formation of filopodia and invasiveness of CRC. The knockdown of NDRG1 led to enhanced dissemination of CRC cells in vivo and correlates with active CDC42 expression. Using clinical sample analysis, we found an elevated level of active CDC42 in patients with advanced T stage, and it was negatively related to NDRG1 expression. In sum, these results uncover a mechanism utilized by NDRG1 to regulate CDC42 activity in coordinating cytoskeleton reorganization, which was crucial in cancer invasion.


Subject(s)
Cell Cycle Proteins/genetics , Colorectal Neoplasms/genetics , Down-Regulation , Gene Expression Regulation, Neoplastic , Intracellular Signaling Peptides and Proteins/genetics , Neoplasm Invasiveness/genetics , Neoplasms, Experimental , Pseudopodia/genetics , Animals , Cell Cycle Proteins/biosynthesis , Cell Line, Tumor , Cell Proliferation , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Humans , Intracellular Signaling Peptides and Proteins/biosynthesis , Male , Mice , Neoplasm Invasiveness/pathology , Pseudopodia/metabolism , Pseudopodia/pathology , RNA, Neoplasm/genetics
5.
Int J Mol Sci ; 22(8)2021 Apr 12.
Article in English | MEDLINE | ID: mdl-33921304

ABSTRACT

Local basement membrane (BM) disruption marks the initial step of breast cancer invasion. The activation mechanisms of force-driven BM-weakening remain elusive. We studied the mechanical response of MCF10A-derived human breast cell acini with BMs of tuneable maturation to physical and soluble tumour-like extracellular matrix (ECM) cues. Traction force microscopy (TFM) and elastic resonator interference stress microscopy (ERISM) were used to quantify pro-invasive BM stress and protrusive forces. Substrate stiffening and mechanically impaired BM scaffolds induced the invasive transition of benign acini synergistically. Robust BM scaffolds attenuated this invasive response. Additional oncogenic EGFR activation compromised the BMs' barrier function, fuelling invasion speed and incidence. Mechanistically, EGFR-PI3-Kinase downstream signalling modulated both MMP- and force-driven BM-weakening processes. We show that breast acini form non-proteolytic and BM-piercing filopodia for continuous matrix mechanosensation, which significantly push and pull on the BM and ECM under pro-invasive conditions. Invasion-triggered acini further shear and compress their BM by contractility-based stresses that were significantly increased (3.7-fold) compared to non-invasive conditions. Overall, the highest amplitudes of protrusive and contractile forces accompanied the highest invasiveness. This work provides a mechanistic concept for tumour ECM-induced mechanically misbalanced breast glands fuelling force-driven BM disruption. Finally, this could facilitate early cell dissemination from pre-invasive lesions to metastasize eventually.


Subject(s)
Breast/metabolism , Epidermal Growth Factor/genetics , Neoplasms/genetics , Acinar Cells/metabolism , Acinar Cells/pathology , Basement Membrane/metabolism , Basement Membrane/pathology , Breast/pathology , Cell Line, Tumor , ErbB Receptors/genetics , Extracellular Matrix/genetics , Extracellular Matrix/pathology , Female , Humans , Mammary Glands, Human/pathology , Mechanical Phenomena , Neoplasm Invasiveness/genetics , Neoplasms/pathology , Pseudopodia/genetics , Pseudopodia/pathology
6.
Cell Prolif ; 54(3): e12994, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33458919

ABSTRACT

OBJECTIVES: Cancer cell migration to secondary organs remains an essential cause of death among breast cancer (BrCa) patients. Cell motility mainly relies on actin dynamics. Our previous reports verified that dishevelled-associated activator of morphogenesis 1 (Daam1) regulates invadopodia extension and BrCa cell motility. However, how Daam1 is involved in actin filament assembly and promotes pseudopodia formation in BrCa cells remains unclear. MATERIALS AND METHODS: One hundred human BrCa samples were collected at Women's Hospital of Nanjing Medical University. Immunohistochemistry (IHC) was used to examine Daam1 and Fascin expression. Wound healing and Boyden chamber assays were used to explore cell migration and pseudopodia extension of BrCa cells. Co-IP/pull down and Western blotting were performed to study the physical interaction between Daam1 and Fascin. Immunofluorescence assays were performed to observe whether Daam1 and Fascin were colocalized and mediated actin filament assembly. RESULTS: Fascin was upregulated in BrCa tissues compared with that in paracarcinoma tissues. The downregulation of Fascin caused a decline in pseudopodia formation and cell motility. Moreover, we found that Daam1 interacted with Fascin via formin homology (FH) domains, especially the FH2 domain. Immunofluorescence assays showed that Daam1 and Fascin partially colocalized to actin filaments, and the knockdown of Daam1 or Fascin failed to colocalize to short and curved actin filaments. CONCLUSIONS: Daam1 specifically binds to Fascin via FH domains and cooperatively facilitates pseudopodia formation and cell migration by promoting actin filament assembly in BrCa.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Breast Neoplasms/pathology , Cell Movement/physiology , Formins/metabolism , Pseudopodia/pathology , Actin Cytoskeleton/metabolism , Breast Neoplasms/metabolism , Formins/pharmacology , Humans , Pseudopodia/metabolism , rho GTP-Binding Proteins/metabolism
7.
Eur J Pharmacol ; 895: 173866, 2021 Mar 15.
Article in English | MEDLINE | ID: mdl-33454376

ABSTRACT

Metastatic breast cancer is a significant contributor to mortality among women, but its complex regulation represents a barrier to precision targeting. In the present study, a graphene-based nanocomposite which probes and selectively inhibits cancer cell motility is described. By controllable coupling of prenylated chalcone xanthohumol, an efficient inhibitor of mitochondrial electron transport chain complex I, with PEGylated graphene oxide nanosheet, a PEG-GO@XN nanocomposite with good stability and biocompatibility is synthesized. PEG-GO@XN is capable of inhibiting mitochondrial oxidative phosphorylation selectively in MDA-MB-231 and MDA-MB-436 metastatic breast cancer cells. PEG-GO@XN reduces the production of ATP, impairs the formation of F-actin cytoskeleton in the lamellipodia, and blocks the migration and invasion of breast cancer cells in vitro, without interfering the proliferation and metabolism of non-cancerous cells. More importantly, PEG-GO@XN suppresses the metastasis of MDA-MB-231 cells to lung in nude mice. PEG-GO@XN abolishes the TGF-ß1-induced down-regulation of E-cadherin and up-regulation of N-cadherin, vimentin, Snail and Twist, thus causes the maintenance of "epithelial-like" rather than the "mesenchymal-like" features, and decreases the motility potential of breast cancer cells. Taken together, this research unveils the enormous potential of PEG-GO@XN to suppress metastatic breast cancer by selective targeting oxidative phosphorylation and epithelial-mesenchymal transition of cancer cells and thereby providing insights on metastatic cancer treatment.


Subject(s)
Antineoplastic Agents/pharmacology , Breast Neoplasms/drug therapy , Epithelial-Mesenchymal Transition/drug effects , Lung Neoplasms/prevention & control , Mitochondria/drug effects , Nanocomposites , Oxidative Phosphorylation/drug effects , Polyethylene Glycols/pharmacology , Actin Cytoskeleton/drug effects , Actin Cytoskeleton/metabolism , Actin Cytoskeleton/pathology , Adenosine Triphosphate/metabolism , Animals , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Movement/drug effects , Drug Compounding , Female , Humans , Lung Neoplasms/metabolism , Lung Neoplasms/secondary , Mice, Inbred BALB C , Mice, Nude , Mitochondria/metabolism , Mitochondria/pathology , Neoplasm Invasiveness , Pseudopodia/drug effects , Pseudopodia/metabolism , Pseudopodia/pathology , Signal Transduction , Xenograft Model Antitumor Assays
8.
Sci Rep ; 10(1): 21103, 2020 12 03.
Article in English | MEDLINE | ID: mdl-33273487

ABSTRACT

Chronic kidney disease is a public health burden and it remains unknown which genetic loci are associated with kidney function in the Japanese population, our genome-wide association study using the Biobank Japan dataset (excluding secondary kidney diseases, such as diabetes mellitus) clearly revealed that almost half of the top 50 single nucleotide polymorphisms associated with estimated glomerular filtration rate are located in the SHROOM3 gene, suggesting that SHROOM3 will be responsible for kidney function. Thus, to confirm this finding, supportive functional analyses were performed on Shroom3 in mice using fullerene-based siRNA delivery, which demonstrated that Shroom3 knockdown led to albuminuria and podocyte foot process effacement. The in vitro experiment shows that knockdown of Shroom3 caused defective formation of lamellipodia in podocyte, which would lead to the disruption of slit diaphragm. These results from the GWAS, in vivo and in vitro experiment were consistent with recent studies reporting that albuminuria leads to impairment of kidney function.


Subject(s)
Genetic Association Studies , Genetic Predisposition to Disease , Microfilament Proteins/genetics , Podocytes/pathology , Renal Insufficiency, Chronic/genetics , Albuminuria/genetics , Albuminuria/physiopathology , Animals , Base Pairing/genetics , Female , Gene Knockdown Techniques , Genetic Loci , Genome-Wide Association Study , Glomerular Filtration Rate , Humans , Intracellular Signaling Peptides and Proteins , Male , Membrane Proteins , Mice , Mice, Inbred C57BL , Podocytes/ultrastructure , Pseudopodia/pathology , Rats , Renal Insufficiency, Chronic/physiopathology
10.
EMBO J ; 39(21): e106003, 2020 11 02.
Article in English | MEDLINE | ID: mdl-32946121

ABSTRACT

Polarised targeting of diverse mRNAs to cellular protrusions is a hallmark of cell migration. Although a widespread phenomenon, definitive functions for endogenous targeted mRNAs and their relevance to modulation of in vivo tissue dynamics remain elusive. Here, using single-molecule analysis, gene editing and zebrafish live-cell imaging, we report that mRNA polarisation acts as a molecular compass that orients motile cell polarity and spatially directs tissue movement. Clustering of protrusion-derived RNAseq datasets defined a core 192-nt localisation element underpinning precise mRNA targeting to sites of filopodia formation. Such targeting of the small GTPase RAB13 generated tight spatial coupling of mRNA localisation, translation and protein activity, achieving precise subcellular compartmentalisation of RAB13 protein function to create a polarised domain of filopodia extension. Consequently, genomic excision of this localisation element and perturbation of RAB13 mRNA targeting-but not translation-depolarised filopodia dynamics in motile endothelial cells and induced mispatterning of blood vessels in zebrafish. Hence, mRNA polarisation, not expression, is the primary determinant of the site of RAB13 action, preventing ectopic functionality at inappropriate subcellular loci and orienting tissue morphogenesis.


Subject(s)
Morphogenesis/genetics , Morphogenesis/physiology , RNA, Messenger/metabolism , rab GTP-Binding Proteins/genetics , rab GTP-Binding Proteins/metabolism , Animals , Cell Movement , Cell Polarity , Endothelial Cells/cytology , Endothelial Cells/metabolism , GTP Phosphohydrolases , Gene Editing , Pseudopodia/metabolism , Pseudopodia/pathology , Zebrafish/embryology , Zebrafish/genetics , Zebrafish/physiology
11.
Exp Cell Res ; 392(2): 112011, 2020 07 15.
Article in English | MEDLINE | ID: mdl-32339607

ABSTRACT

Ovarian cancer cells shed from primary tumors can spread easily to the peritoneum via the peritoneal fluid. To allow further metastasis, the cancer cells must interact with the mesothelial cell layer, which covers the entire surface of the peritoneal organs. Although the clinical importance of this interaction between cancer and mesothelial cells has been increasingly recognized, the molecular mechanisms utilized by cancer cells to adhere to and migrate through the mesothelial cell layer are poorly understood. To investigate the molecular mechanisms of cancer cell trans-mesothelial migration, we set up an in vitro trans-mesothelial migration assay using primary peritoneal mesothelial cells. Using this method, we found that downregulation of filopodial protein fascin-1 or myosin X expression in ES-2 cells significantly inhibited the rate of trans-mesothelial migration of cancer cells, whereas upregulation of fascin-1 in SK-OV-3 cells enhanced this rate. Furthermore, downregulation of N-cadherin or integrin ß1 inhibited the rate of cancer cell trans-mesothelial migration. Conversely, downregulation of cortactin or TKS5 or treatment with the MMP inhibitor GM6001 or the N-WASP inhibitor wiskostatin did not have any effect on cancer cell trans-mesothelial migration. These results suggest that filopodia, but not lamellipodia or invadopodia, play an important role in the trans-mesothelial migration of ovarian cancer cells.


Subject(s)
Carrier Proteins/metabolism , Cell Movement , Epithelium/pathology , Microfilament Proteins/metabolism , Ovarian Neoplasms/pathology , Peritoneal Neoplasms/secondary , Pseudopodia/pathology , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Carrier Proteins/genetics , Cell Adhesion , Epithelium/metabolism , Female , Humans , Integrin beta1/genetics , Integrin beta1/metabolism , Microfilament Proteins/genetics , Myosins/genetics , Myosins/metabolism , Ovarian Neoplasms/genetics , Ovarian Neoplasms/metabolism , Peritoneal Neoplasms/genetics , Peritoneal Neoplasms/metabolism , Prognosis , Pseudopodia/genetics , Pseudopodia/metabolism , Survival Rate , Tumor Cells, Cultured
12.
Cell Death Dis ; 11(2): 98, 2020 02 06.
Article in English | MEDLINE | ID: mdl-32029735

ABSTRACT

Amyloid beta peptides (Aß) proteins play a key role in vascular pathology in Alzheimer's Disease (AD) including impairment of the blood-brain barrier and aberrant angiogenesis. Although previous work has demonstrated a pro-angiogenic role of Aß, the exact mechanisms by which amyloid precursor protein (APP) processing and endothelial angiogenic signalling cascades interact in AD remain a largely unsolved problem. Here, we report that increased endothelial sprouting in human-APP transgenic mouse (TgCRND8) tissue is dependent on ß-secretase (BACE1) processing of APP. Higher levels of Aß processing in TgCRND8 tissue coincides with decreased NOTCH3/JAG1 signalling, overproduction of endothelial filopodia and increased numbers of vascular pericytes. Using a novel in vitro approach to study sprouting angiogenesis in TgCRND8 organotypic brain slice cultures (OBSCs), we find that BACE1 inhibition normalises excessive endothelial filopodia formation and restores NOTCH3 signalling. These data present the first evidence for the potential of BACE1 inhibition as an effective therapeutic target for aberrant angiogenesis in AD.


Subject(s)
Amyloid Precursor Protein Secretases/metabolism , Amyloid beta-Protein Precursor/metabolism , Aspartic Acid Endopeptidases/metabolism , Cerebral Cortex/blood supply , Endothelial Cells/enzymology , Neovascularization, Pathologic , Receptor, Notch3/metabolism , Amyloid Precursor Protein Secretases/antagonists & inhibitors , Amyloid beta-Protein Precursor/genetics , Animals , Aspartic Acid Endopeptidases/antagonists & inhibitors , Endothelial Cells/drug effects , Endothelial Cells/pathology , Enzyme Inhibitors/pharmacology , Female , In Vitro Techniques , Jagged-1 Protein/genetics , Jagged-1 Protein/metabolism , Male , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Transgenic , Microvascular Density , Pseudopodia/enzymology , Pseudopodia/pathology , Signal Transduction
13.
Oncogene ; 39(2): 385-398, 2020 01.
Article in English | MEDLINE | ID: mdl-31477838

ABSTRACT

Tumor invasion and metastasis are the major causes of treatment failure and mortality in lung cancer patients. In this study, we identified a group of genes with differential expression in in situ and invasive lung adenocarcinoma tissues by expression profiling; among these genes we further characterized the association of the upregulation of PRNP, the gene encoding cellular Prion protein (PrPc), with lung adenocarcinoma invasiveness. Immunohistochemistry on clinical specimens showed an association of PrPc expression with invasive but not in situ lung adenocarcinoma. Consistently, the expression of PrPc was higher in the highly invasive than in the lowly invasive lung adenocarcinoma cell lines. Knockdown of PrPc expression in cultured lung adenocarcinoma cells decreased their lamellipodium formation, in vitro migration and invasion, and in vivo experimental lung metastasis. Phosphorylation of JNKs was found to correlate with PrPc expression and the inhibition of JNKs suppressed the PrPc-induced up-regulation of lamellipodium formation, cell migration, and invasion. Moreover, we identified the nuclear factor, interleukin 3 regulated (NFIL3) protein as a transcriptional activator of the PRNP promoter. Accordingly, NFIL3 promoted lung cancer cell migration and invasion in a PrPc-dependent manner. High NFIL3 expression in clinical specimens of lung adenocarcinoma was also associated with tumor invasiveness. Overall, our observations suggest that the NFIL3/PrPc axis, through regulating lamellipodium formation and cell mobility via JNK signaling, plays a critical role in lung cancer invasiveness and metastasis.


Subject(s)
Basic-Leucine Zipper Transcription Factors/genetics , Lung Neoplasms/genetics , Prion Proteins/genetics , Pseudopodia/genetics , Animals , Cell Movement/genetics , Cell Proliferation/genetics , Female , Gene Expression Regulation, Neoplastic/genetics , Humans , In Situ Hybridization , Lung Neoplasms/pathology , MAP Kinase Signaling System/genetics , Male , Mice , Neoplasm Invasiveness/genetics , Neoplasm Invasiveness/pathology , Neoplasm Metastasis , Oligonucleotide Array Sequence Analysis/methods , Promoter Regions, Genetic/genetics , Pseudopodia/pathology
14.
Auris Nasus Larynx ; 47(1): 98-104, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31272842

ABSTRACT

OBJECTIVE: Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a disease that features a mechanical dysfunction involving chronic inflammation and altered tissue remodeling. In this study, we aim to evaluate the fibroblast morphology and its cellular traction force in primary fibroblasts cell cultures obtained from both healthy individuals (n=7) and patients with CRSwNP (n=8). METHODS: Using a Traction-force Microscopy we analyzed parameters of Force/Tension in fibroblasts cultures in both experimental groups. RESULTS: The analysis of the Projected Area of Cell revealed that fibroblasts derived from nasal mucosa of healthy individuals have an area on average 39.24% larger than the fibroblasts obtained from the nasal polyp tissue. We also observed that the parameters directly related to the force of the cell, Max Cumulative Force and Net Contractile Moment, presented a high Force/Tension per unit of area in the fibroblasts derived from the healthy nasal mucosa (on average 41% and 52.54% higher than the fibroblasts of the nasal polyp respectively). CONCLUSION: Our results demonstrate a cellular mechanism that may be associated with the mechanical dysfunction found in the Nasal Polyp tissue. The weak traction force of nasal polyp-derived fibroblast may, in lower dimensions, impact on the remodeling of nasal mucosa in CRSwNP.


Subject(s)
Biomechanical Phenomena , Fibroblasts/ultrastructure , Nasal Polyps/ultrastructure , Pseudopodia/ultrastructure , Case-Control Studies , Chronic Disease , Female , Fibroblasts/pathology , Fibroblasts/physiology , Humans , Male , Microscopy, Atomic Force , Microscopy, Phase-Contrast , Middle Aged , Nasal Polyps/pathology , Nasal Polyps/physiopathology , Primary Cell Culture , Pseudopodia/pathology , Rhinitis/pathology , Sinusitis/pathology
15.
Nat Commun ; 10(1): 3593, 2019 08 09.
Article in English | MEDLINE | ID: mdl-31399564

ABSTRACT

Filopodia, dynamic membrane protrusions driven by polymerization of an actin filament core, can adhere to the extracellular matrix and experience both external and cell-generated pulling forces. The role of such forces in filopodia adhesion is however insufficiently understood. Here, we study filopodia induced by overexpression of myosin X, typical for cancer cells. The lifetime of such filopodia positively correlates with the presence of myosin IIA filaments at the filopodia bases. Application of pulling forces to the filopodia tips through attached fibronectin-coated laser-trapped beads results in sustained growth of the filopodia. Pharmacological inhibition or knockdown of myosin IIA abolishes the filopodia adhesion to the beads. Formin inhibitor SMIFH2, which causes detachment of actin filaments from formin molecules, produces similar effect. Thus, centripetal force generated by myosin IIA filaments at the base of filopodium and transmitted to the tip through actin core in a formin-dependent fashion is required for filopodia adhesion.


Subject(s)
Formins/metabolism , Myosins/metabolism , Neoplasms/metabolism , Nonmuscle Myosin Type IIA/metabolism , Pseudopodia/physiology , Actin Cytoskeleton , Animals , COS Cells , Chlorocebus aethiops , Formins/antagonists & inhibitors , Formins/genetics , Formins/ultrastructure , Gene Expression Regulation, Neoplastic , HeLa Cells , Humans , Microfilament Proteins , Nonmuscle Myosin Type IIA/antagonists & inhibitors , Nonmuscle Myosin Type IIA/genetics , Nonmuscle Myosin Type IIA/ultrastructure , Pseudopodia/pathology , Thiones/pharmacology , Uracil/analogs & derivatives , Uracil/pharmacology
16.
Biochem Biophys Res Commun ; 516(3): 831-838, 2019 08 27.
Article in English | MEDLINE | ID: mdl-31262449

ABSTRACT

The promising anti-tumor effects of oncolytic vaccinia virus (OVV) have been demonstrated. Further, we previously showed that long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) enhances OVV cell-to-cell spread via the activation of Cdc42 in ovarian cancer. However, its role in other cancer types and the molecular mechanism underlying its effects remain to be explored. In this study, we first demonstrated that UCA1 upregulates OVV cell-to-cell spread but not its binding, entry, and replication in colorectal cancer cells. Functional analysis indicated that Cdc42 activation and filopodia formation play an important role in this process. Moreover, expression analysis of various miRNAs suggested that UCA1 inhibits both miR-18a and miR-182, thereby promoting Cdc42 activation, which in turn, regulates OVV cell-to-cell spread. Furthermore, UCA1 was found to modulate tumor malignancy, drug resistance, and sensitivity to OVV via different miRNAs in colorectal cancer. These findings indicate that a three-marker panel, which includes UCA1 expression, Cdc42 activation, and filopodia formation, could potentially be used to predict the therapeutic effect of OVV in colorectal cancer.


Subject(s)
Gene Expression Regulation, Neoplastic , MicroRNAs/genetics , RNA, Long Noncoding/genetics , Vaccinia virus/genetics , cdc42 GTP-Binding Protein/genetics , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Caco-2 Cells , Cell Proliferation , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Colorectal Neoplasms/therapy , HCT116 Cells , HT29 Cells , Humans , MicroRNAs/metabolism , Oncolytic Virotherapy/methods , Oncolytic Viruses/genetics , Oncolytic Viruses/metabolism , Pseudopodia/metabolism , Pseudopodia/pathology , RNA, Long Noncoding/metabolism , Signal Transduction , Vaccinia virus/metabolism , Virus Replication , cdc42 GTP-Binding Protein/metabolism
17.
Dev Cell ; 49(3): 444-460.e9, 2019 05 06.
Article in English | MEDLINE | ID: mdl-31063759

ABSTRACT

Actin assembly supplies the structural framework for cell morphology and migration. Beyond structure, this actin framework can also be engaged to drive biochemical signaling programs. Here, we describe how the hyperactivation of Rac1 via the P29S mutation (Rac1P29S) in melanoma hijacks branched actin network assembly to coordinate proliferative cues that facilitate metastasis and drug resistance. Upon growth challenge, Rac1P29S-harboring melanoma cells massively upregulate lamellipodia formation by dendritic actin polymerization. These extended lamellipodia form a signaling microdomain that sequesters and phospho-inactivates the tumor suppressor NF2/Merlin, driving Rac1P29S cell proliferation in growth suppressive conditions. These biochemically active lamellipodia require cell-substrate attachment but not focal adhesion assembly and drive proliferation independently of the ERK/MAPK pathway. These data suggest a critical link between cell morphology and cell signaling and reconcile the dichotomy of Rac1's regulation of both proliferation and actin assembly by revealing a mutual signaling axis wherein actin assembly drives proliferation in melanoma.


Subject(s)
Dendritic Cells/metabolism , Melanoma/metabolism , Pseudopodia/metabolism , rac1 GTP-Binding Protein/metabolism , Actins/metabolism , Animals , Cell Line, Tumor , Cell Movement/physiology , Cell Proliferation/physiology , Dendrites/metabolism , Dendrites/pathology , Female , Heterografts , Humans , MAP Kinase Signaling System , Melanoma/pathology , Mice , Mice, Inbred NOD , Mice, SCID , Mutation , Neoplasm Metastasis , Pseudopodia/pathology , rac1 GTP-Binding Protein/genetics
18.
Virchows Arch ; 475(2): 245-249, 2019 Aug.
Article in English | MEDLINE | ID: mdl-30852641

ABSTRACT

BACKGROUND: Rhabdoid colorectal carcinoma (RC) is a rare lesion localized to the proximal colon of patients with a mean age at diagnosis of around 70 years. This tumor shows an aggressive behavior with an overall survival period shorter than 12 months. The diagnostic hallmark is the presence of rhabdoid cells. Alterations in chromatin remodeling (SMARCB1) and in the centrosome structure (CROCC) are reported in RC usually BRAFmut and MSI-H. RKO intestinal neoplastic cells culture (BRAFmut, SMARCB1wt, MSI-H) with CROCC knockdown exhibit rhabdoid features and develop prominent projections from the edge of the cell. METHODS: Here, we investigated two cases of CROCCmutSMARCB1wt RC by scanning and transmission electron microscopy (SEM, TEM). RESULTS: TEM confirmed the diagnostic presence of intermediate cytoplasmic filaments and nucleolar margination. SEM showed cellular protrusions (lamellipodia) in the intercellular spaces not evident at light microscopy. CONCLUSIONS: These protrusions CROCC-related might represent the pathogenetic mechanism underlying the rhabdoid aggressive behavior, independently of tumor staging. To our knowledge, the SEM technique was applied in the study of this neoplasm for the first time.


Subject(s)
Adenocarcinoma/ultrastructure , Colorectal Neoplasms/ultrastructure , Cytoskeletal Proteins/genetics , Rhabdoid Tumor/ultrastructure , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Aged , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Female , Humans , Microscopy, Electron , Pseudopodia/pathology , Pseudopodia/ultrastructure , Rhabdoid Tumor/genetics , Rhabdoid Tumor/pathology
19.
J Cell Sci ; 132(5)2019 02 18.
Article in English | MEDLINE | ID: mdl-30718364

ABSTRACT

The actin cytoskeleton is the engine that powers the inflammatory chemotaxis of immune cells to sites of tissue damage or infection. Here, we combine genetics with live in vivo imaging to investigate how cytoskeletal rearrangements drive macrophage recruitment to wounds in Drosophila We find that the actin-regulatory protein Ena is a master regulator of lamellipodial dynamics in migrating macrophages, where it remodels the cytoskeleton to form linear filaments that can then be bundled together by the cross-linker Fascin (also known as Singed in flies). In contrast, the formin Dia generates rare, probing filopods for specialised functions that are not required for migration. The role of Ena in lamellipodial bundling is so fundamental that its overexpression increases bundling even in the absence of Fascin by marshalling the remaining cross-linking proteins to compensate. This reorganisation of the lamellipod generates cytoskeletal struts that push against the membrane to drive leading edge advancement and boost cell speed. Thus, Ena-mediated remodelling extracts the most from the cytoskeleton to power robust macrophage chemotaxis during their inflammatory recruitment to wounds.


Subject(s)
Actin Cytoskeleton/metabolism , DNA-Binding Proteins/metabolism , Drosophila Proteins/metabolism , Drosophila/physiology , Formins/metabolism , Inflammation/metabolism , Macrophages/metabolism , Multiprotein Complexes/metabolism , Animals , Animals, Genetically Modified , Carrier Proteins/metabolism , Chemotaxis , DNA-Binding Proteins/genetics , Drosophila Proteins/genetics , Formins/genetics , Macrophages/pathology , Microfilament Proteins/metabolism , Protein Binding , Pseudopodia/pathology , Wound Healing
20.
Indian J Pathol Microbiol ; 62(1): 117-118, 2019.
Article in English | MEDLINE | ID: mdl-30706873

ABSTRACT

Pleomorphic adenoma is the most common salivary gland tumor. Pseudopodia are finger-like projections extending beyond the tumor capsule, seen in pleomorphic adenoma. If not resected completely, these pseudopodia may increase the risk of recurrence after excision of pleomorphic adenoma. While performing a total conservative parotidectomy for the pleomorphic adenoma of the parotid gland, we encountered tumor in the Stensen's duct. On pathological examination, the tumor was not involving the wall of the duct but was passing through the lumen, like a pseudopod. During parotidectomy, the surgeon should inspect the lumen of parotid duct for the presence of any tumor. Pseudopodia of pleomorphic adenoma may extend into the lumen and if not addressed adequately may lead to recurrence of the tumor.


Subject(s)
Adenoma, Pleomorphic/diagnosis , Parotid Neoplasms/diagnosis , Pseudopodia/pathology , Salivary Ducts/pathology , Adenoma, Pleomorphic/pathology , Adenoma, Pleomorphic/surgery , Humans , Male , Middle Aged , Parotid Gland/pathology , Parotid Neoplasms/pathology , Parotid Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...